Initiation of triple therapy maintenance treatment among patients with COPD in the US

BACKGROUND: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends triple therapy (long-acting muscarinic receptor antagonists, long-acting beta-2 agonists, and inhaled corticosteroids) for patients with only the most severe COPD. Data on the proportion of COPD patients on trip...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeone, Jason C, Luthra, Rakesh, Kaila, Shuchita, Pan, Xiaoyun, Bhagnani, Tarun D, Liu, Jieruo, Wilcox, Teresa K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191839/
https://www.ncbi.nlm.nih.gov/pubmed/28053518
http://dx.doi.org/10.2147/COPD.S122013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191839/
https://www.ncbi.nlm.nih.gov/pubmed/28053518
http://dx.doi.org/10.2147/COPD.S122013

Ejemplares similares